Advertisement Par Pharmaceutical begins shipment of generic Imitrex injection - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Par Pharmaceutical begins shipment of generic Imitrex injection

Par Pharmaceutical Companies, a developer and marketer of generic drugs, has announced that it will begin shipping generic versions of Imitrex injection 4mg and 6mg starter kits and 4mg and 6mg prefilled syringe cartridges. In addition, Par anticipates launching the 6mg vials in early 2009.

Sumatriptan succinate injection is indicated for the acute treatment of migraine attacks with or without aura and the acute treatment of cluster headache episodes. Sumatriptan succinate injection is not for use in the management of hemiplegic or basilar migraine.